Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Abcellera Biologics Inc
NASDAQ:ABCL
Abcellera Biologics Inc
NASDAQ:ABCL
Price:
12.955
USD
3.27%
Market Cap:
$4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
CA |
|
S
|
Samart Telcoms PCL
SET:SAMTEL
|
TH |
|
Redox Ltd
F:AE0
|
AU |
|
Centurion Finance ASI SA
F:6F4
|
PL |
|
B
|
Business Engineering Corp
XMUN:TBY
|
JP |
|
F
|
Fuelstream Inc
OTC:FLST
|
US |
|
Searchlight Resources Inc
F:2CC
|
CA |
|
Neometals Ltd
OTC:NMTAF
|
AU |
|
G
|
Golcap Resources Corp
CNSX:GCP
|
CA |
|
A
|
Amneal Intermediate Inc
NASDAQ:AMRX
|
US |
|
Indel B SpA
F:2I6
|
IT |
|
P
|
PharmaRoth Labs Inc
OTC:ROTH
|
US |
|
N
|
Northern Minerals Ltd
F:NUN
|
AU |
|
H
|
Hapag Lloyd AG
F:HLAG
|
DE |
|
E
|
EcoSynthetix Inc
OTC:ECSNF
|
CA |
|
G
|
Goldrea Resources Corp
F:GOJ1
|
CA |
|
C
|
Cassiar Gold Corp
OTC:CGLCF
|
CA |
|
D
|
DaVita Inc
F:TRL
|
US |
|
G
|
GH Research PLC
F:1KA
|
IE |
Wall St Price Targets
ABCL Price Forecast
Based on 12 analysts
Based on 12 analysts
+18% Upside
from
$12.955
today
Abcellera Biologics Inc (ABCL)’s 12-month stock price forecast through October 2027 has a consensus target of $15.3, implying 18% upside. The forecast is based on price targets from 12 Wall Street analysts.
ABCL Analyst Rating
Based on 11 analysts
Based on 11 analysts
Analysts rate ABCL Strong buy, with 10 of 11 recommending Buy or Strong buy.
Abcellera Biologics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABCL's stock price target?
Price Target
15.3
USD
15.3
USD
According to Wall Street analysts, the average 1-year price target for ABCL is 15.3 USD with a low forecast of 9.09 USD and a high forecast of 31.5 USD.
What is the Revenue forecast for Abcellera Biologics Inc?
Projected CAGR
33%
33%
Over the last 6 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is 33%.